Skip to main content
Cantourage Group SE logo

Cantourage Group SE — Investor Relations & Filings

Ticker · HIGH ISIN · DE000A3DSV01 LEI · 3912003NCTLO6YHA9V48 XMIL Manufacturing
Open in API
Filings indexed 109 across all filing types
Latest filing 2023-05-24 Regulatory Filings
Country DE Germany
Listing XMIL HIGH

About Cantourage Group SE

https://www.cantourage.com/

Cantourage Group SE is a company specializing in the production and distribution of medical cannabis. It operates a platform that enables global cultivators to access the European market by managing the import, processing, and distribution of cannabis products. The company processes raw materials from its international partners into EU-compliant finished medicinal products, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Its portfolio features a diverse range of cannabis strains. Additionally, Cantourage operates the 'Telecan' telemedicine platform to facilitate patient access to cannabis-based therapies. The company's strategy involves developing new cannabis medicines and working to lower the cost of treatment for patients.

Recent filings

Filing Released Lang Actions
Cantourage Group SE: Established cannabis brand from Canada: Cantourage brings Breathing Green to German pharmacies
Regulatory Filings Classification · 100% confidence The document is a news release dated May 24, 2023, distributed via EQS-News. It announces a business development: Cantourage Group SE is bringing the Canadian cannabis brand 'Breathing Green' to German pharmacies. The content focuses on a market launch and partnership, not on periodic financial results (like 10-K or IR), management changes (MANG), or shareholder voting (DVA). Since it is a general corporate announcement disseminated through a news service (EQS) that doesn't fit into the more specific categories like ER, CAP, or DIV, it falls best under the general Regulatory Filings/News category, which is RNS, as it is a standard corporate news dissemination.
2023-05-24 English
Cantourage Group SE generates profit in first quarter of 2023
Earnings Release Classification · 100% confidence The document is a news release dated May 11, 2023, announcing that 'Cantourage Group SE generates profit in first quarter of 2023'. It explicitly mentions preliminary and unaudited figures for Q1 2023 sales and profit. This content structure—announcing key financial results for a specific period (quarterly) immediately after the period ends—is characteristic of an Earnings Release (ER). It is not the full, comprehensive report (IR) nor is it a transcript (CT) or a management discussion (MDA), but the initial highlight announcement. Q1 2023
2023-05-11 English
Cantourage Group SE exportiert erstmals Dronabinol und CBD nach Kroatien
Regulatory Filings Classification · 99% confidence The document is a news release dated April 25, 2023, originating from EQS-News, which is a service for distributing corporate news. The content announces a business development: Cantourage Group SE exporting Dronabinol and CBD to Croatia for the first time. It mentions recent revenue growth and provides company background. Crucially, it is structured as a standard press release/news announcement, not a comprehensive regulatory filing like a 10-K or a detailed financial report like an IR. Since it is a general corporate announcement distributed via a news service that doesn't fit neatly into specific financial report categories (like ER, IR, or DIV), the most appropriate classification is the general regulatory/news announcement fallback category, RNS (Regulatory Filings). The length (7222 chars) is substantial enough that it's not just a brief 'publication announcement' (RPA), but a substantive news item.
2023-04-25 German
Cantourage Group SE: Heute schon legal: PURIZE und Cantourage klaren gemeinsam uber den Weg zum Cannabisrezept auf
Environmental & Social Information Classification · 99% confidence The document is a press release dated April 20, 2023, announcing a joint educational campaign between PURIZE® and Cantourage Group SE regarding legal access to prescription cannabis in Germany. It details a business cooperation and provides company overviews. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general news announcement about a business initiative, and it is distributed via EQS News, it fits best under the general regulatory/news announcement category, which is RNS, as it doesn't fit the more specific categories like DIV, CAP, or MANG. It is a general corporate announcement.
2023-04-20 German
Vierter Craft-Anbauer Cantourage gibt Partnerschaft mit Plantations Ceres aus Kanada bekannt
Regulatory Filings Classification · 100% confidence The document is a news release dated April 14, 2023, originating from Cantourage Group SE, distributed via EQS News. The content announces a new business partnership with a Canadian cultivator (Plantations Cérès) to bring a specific cannabis strain to the German medical market. It discusses business strategy, market expansion, and product offerings, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It is a general corporate announcement regarding business development and market entry. Since it is a general corporate news item that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director's Dealing (DIRS), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate news announcements not covered by other specific codes.
2023-04-14 German
Cantourage Group SE: Strong revenue growth in 2022 and Q1 2023 based on preliminary figures
Earnings Release Classification · 100% confidence The document is a news release dated April 12, 2023, titled "Cantourage Group SE: Strong revenue growth in 2022 and Q1 2023 based on preliminary figures." It explicitly states that the figures are preliminary and unaudited, providing key financial highlights (revenue figures for FY 2022 and Q1 2023) and management commentary. This format, focusing on key financial results for a period without being the full, comprehensive report (like a 10-K or IR), aligns perfectly with the definition of an Earnings Release (ER). It is not a full Annual Report (10-K) or an Interim Report (IR) as it only provides preliminary highlights and commentary, not the full set of required financial statements and notes. Q1 2023
2023-04-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.